Evidence map›Paper›PMID 28919715›Full record

ArticleDrug design, development and therapy2017

In vitro inhibitory activities of magnolol against

Peiru Zhou, Jingya Fu, Hong Hua, Xiaosong Liu

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanistic insights of magnolol antimicrobial activity againstFrontiers in cellular and infection microbiology · 2023
    Article
  4. Article
  5. Magnolol as a potent antifungal agent inhibitsFrontiers in cellular and infection microbiology · 2022
    Article
  6. Article
  7. In vitro Antifungal Effects of Berberine AgainstDrug design, development and therapy · 2020
    Article
  8. Article
  9. Insights on the Multifunctional Activities of Magnolol.BioMed research international · 2019
    Review
  10. NewMolecules (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Peiru ZhouDepartment of Oral Medicine, Peking University School and Hospital of Stomatology.
Jingya FuDepartment of Stomatology, Peking University International Hospital, Beijing, People's Republic of China.
Hong HuaDepartment of Oral Medicine, Peking University School and Hospital of Stomatology.
Xiaosong LiuDepartment of Oral Medicine, Peking University School and Hospital of Stomatology.
King University · USPeking University International Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsBiofilmsBiphenyl CompoundsCandidaCandida albicansDrug Resistance, FungalFluconazoleLignansMicrobial Sensitivity TestsPlanktonAntifungal AgentsBiphenyl CompoundsFluconazoleLignansmagnololbiofilmCandida spp.inhibitionmagnolol

Identifiers

PMID28919715
PMCPMC5593404
OpenAlexW2752717603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.